News

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...
The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...
Ending the spread of HIV in Arizona may become more difficult if federal funding is cut or eliminated. Phoenix is trying to ...
Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.